April 18, 2013
Ver artículo completoIdentification of Therapeutic Benefit from Revascularization in Patients With Left Ventricular Systolic Dysfunction
PICO estructurado
Does revascularization improve survival compared to medical therapy in patients with ischemic cardiomyopathy based on the presence of hibernating myocardium?
P
Población
Patients with ischemic cardiomyopathy and left ventricular systolic dysfunction
I
Intervención
Revascularization
C
Comparador
Medical therapy
O
Resultado
Survivalhard clinical
In patients with ischemic cardiomyopathy, the presence of hibernating myocardium, rather than ischemia, identifies those who may gain a survival benefit from revascularization.
Resumen
Among patients with ischemic cardiomyopathy, hibernating, but not ischemic, myocardium identifies which patients may accrue a survival benefit with revascularization versus medical therapy.